I advise for-profit companies operating in the NICU and maternal-infant health space, including those working with human milk, donor milk, fortification, breastfeeding technologies, and milk biobanking, with an emphasis on critically ill, preterm infants.
My lactation-centered, nurse-scientist informed strategies help organizations translate science into safe, ethical, and evidence-driven products that advance maternal-infant health.
